Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Allograft rejection | R-HSA-9679028 | map05330 | cinnarizine | 1547484 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | cinnarizine | 1547484 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | cinnarizine | 1547484 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | cinnarizine | 1547484 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | cinnarizine | 1547484 | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | cinnarizine | 1547484 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | cinnarizine | 1547484 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | methylprednisolone | 6741 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | methylprednisolone | 6741 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | methylprednisolone | 6741 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | methylprednisolone | 6741 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | methylprednisolone | 6741 | drug-path |
Asthma | R-HSA-444620 | map05310 | methylprednisolone | 6741 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | methylprednisolone | 6741 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | methylprednisolone | 6741 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | methylprednisolone | 6741 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | methylprednisolone | 6741 | drug-path |
Gap junction | R-HSA-190861 | map04540 | methylprednisolone | 6741 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | methylprednisolone | 6741 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | methylprednisolone | 6741 | drug-path |